Moderate supplementation with natural α-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 177-185

  Mabile, Laurence ^a   Bruckdorfer, K Richard ^b   Rice Evans, Catherine ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Tocopherol; LDL oxidation; Platelet function; Prostaglandin E1

Indexed keywords

ALPHA TOCOPHEROL; BETA THROMBOGLOBULIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; DOSE RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUPPLEMENTATION; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ADULT; ALPROSTADIL; BETA-THROMBOGLOBULIN; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; VITAMIN E;

EID: 0032874496     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00169-0     Document Type: Article

References (62)

1. Trip D.M., Cats M.V., van Capelle L.J.F., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 22:1990;1549-1554.
2. Elwood P.C., Renaud S., Sharp D.S., Beswick A.D., O'Brien J.R., Yarnell J.W.G. Ischemic heart disease and platelet aggregation. The Caerphilly collaborative heart disease study. Circulation. 83:1991;39-40.
3. Steinberg D., Parthasarthy S., Carew T., Khoo J.C., Wiztum J.L. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915.
4. Regnstrom J., Nilsson J., Tornvall P., Landau C., Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186.
5. Jacobs M., Plane F., Bruckdorfer K.R. Native and oxidised LDL have differential inhibitory effects on endothelium-derived relaxing factor in rabbit aorta. B. J. Pharmacol. 100:1990;21-26.
6. Stoll L.L., Osjarsson H.J., Spector A.A. Interaction of lysophosphatidylcholine with aortic endothelial cells. Am. J. Physiol. 262:1992;H1853-H1860.
7. Bruckdorfer K.R. The effects of plasma lipoproteins on platelet responsiveness and on platelet and vascular prostanoid synthesis. Prostagland Leukotr. Ess. Fatty Acids. 38:1989;247-254.
8. Meraji S., Moore C.E., Skinner V.O., Bruckdorfer K.R. The importance of oxidation and glycosylation of low density lipoproteins on platelet function. Platelets. 3:1992;155-162.
9. Weidtmann A., Scheithe R., Hrboticky N., Pietsch A., Lorenz R., Siess W. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 15:1995;1131-1138.
10. Naseem K.M., Goodhall A.H., Bruckdorfer K.R. Differential effects of native oxidatively modified lipoproteins on platelet function. Platelets. 8:1997;163-173.
11. Kulmacz R.J., Lands W.E.M. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins. 25:1983;531-540.
12. Rice-Evans C.A., Bruckdorfer K.R. Free radicals, lipoproteins and cardiovascular dysfunction. Mol. Aspect. Med. 13:1992;1-111.
13. Kok F.J., de Bruijn A.M., Vermeeren R. Serum selenium, vitamin antioxidants and cardiovascular mortality: a year follow-up study in the Netherlands. Am. J. Clin. Nutr. 45:1987;462-468.
14. Hense H.W., Stender M., Bors W., Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis. 103:1993;28.
15. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Coldicz G.A., Willett W.C. Vitamin E consumption and the risk of coronary disease in woman. N. Engl. J. Med. 328:1993;1450-1456.
16. Stampfer M.J., Henneckens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1993;1444-1449.
17. Diplock A.T. Antioxidants and disease prevention. Mol. Aspects Med. 15:1994;293-376.
18. Odeh R.M., Cornish L.A. Natural antioxidants for the prevention of atherosclerosis. Pharmacotherapy. 15:1995;648-659.
19. Stephens N.G., Parsons A., Schonfield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant (CHAOS). Lancet. 347:1996;718-786.
20. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13:1992;341-390.
21. Princen H.M.G., van Duyvenvoorde W., Buytenhek R., van der Laarse A., van Poppel G., Gevers Leuven J.A., van Hinsbergh V.W.M. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler. Thromb. Vasc. Biol. 15:1995;325-333.
22. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and β-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl 97S-103S.
23. Reaven P., Khouw A., Betz W., Parthasarathy S., Witztum J.L. Effect of dietary antioxidant combinations in humans: protection of low density lipoproteins by vitamin E but not by β-carotene. Arterioscler. Thromb. 13:1993;590-600.
24. Steiner M. Vitamin E changes membrane fluidity of human platelets. Biochim. Biophys. Acta. 640:1981;100-105.
25. Steiner M., Anastasi J. Vitamin E, an inhibitor of the platelet release reaction. J. Clin. Invest. 57:1976;732-737.
26. Fong J.S.C. Alpha-tocopherol: its inhibition on human platelet aggregation. Experientia. 32:1976;639-641.
27. White J.G., Rao G.H.R, Gerrard J.M. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation and secretion. Am. J. Pathol. 88:1977;387-401.
28. Steiner M. Effect of alpha-tocopherol administration on platelet function in man. Thromb. Haemost. 49:1983;73-77.
29. Richardson P.D., Mohammed S.F., Mason R.G. Flow chamber studies of platelet adhesion at controlled spatially varied shear rates. Proc. Eur. Soc. Artif. Organs. 4:1977;175-188.
30. Stampfer M.J., Jakubowski J.A., Faigel D., Vaillancourt R., Deykin D. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism and plasma prostacyclin levels. Am. J. Clin. Nutr. 47:1988;700-706.
31. Kockmann V., Véricel E., Croset M., Largarde M. Vitamin E fails to alter the aggregation and the oxygenated metabolism of arachidonic acid in normal human platelets. Prostaglandins. 36:1988;607-620.
32. Salonen J.Y., Salonen R., Seppanen K., Rinta-Kiikka S., Kuukka M., Korpela H., Alfthan G., Kantola M., Schalch W. Effects of antioxidant supplementation on platelet function; a randomised pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am. J. Clin. Nutr. 53:1991;1222-1229.
33. Calazada C., Bruckdorfer K.R., Rice-Evans C.A. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis. 128:1997;97-105.
34. Lagarde M., Burtin M., Berciaud P., Blanc M., Velardo B., Dechanave M. Increase of platelet thromboxane A2 formation and its plasmatic half-life in diabetes mellitus. Thromb. Res. 19:1980;823-830.
35. Warnick GR. Enzymatic methods for quantification of lipoproteins lipids, In: Colowick N, Kaplan O, editors. Methods in Enyzmol. London: Academic Press, 1986;129:101-123.
36. 2. Clin. Chem. 29:1983;2026-2030.
37. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
38. Rice-Evans CA, Diplock AT, Symons MRC. In: Techniques in Free Radical Research. Amsterdam: Elsevier, 1991.
39. Chung B.H., Wilkinson T., Geer J.C., Segrest J.C. Preparative and quantitative isolation of plasma lipoprotein s: rapid single discontinuous density gradient ultracentrifugation in the vertical rotor. J. Lipid Res. 221:1980;284-317.
40. Markwell M.A., Hass S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein. Anal. Biochem. 87:1978;206-210.
41. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoproteins. Free Rad. Res. Comm. 6:1989;67-75.
42. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927.
43. Gey K.F., Moser U.K., Jordan P., Stahelin H.B., Eichholzer M., Luedin E. Increased risk of cardiovascular disease at sub-optimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 57:1993;787S-797S.
44. Riemersma R.A., Wood D.A., Macintyre C.C.A., Elton R.A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C and E, and carotene. Lancet. 337:1991;1-5.
45. Jessup W., Rankin S.M., De Whalley C.V., Hoult J.R.S., Scott J., Leake D.S. Tocopherol consumption during low-density lipoprotein oxidation. Biochem. J. 265:1990;399-405.
46. Dieber-Rotheneder M., Puhl H., Waeg G., Striegel G., Esterbauer H. Effect of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoproteins and its oxidative resistance. J. Lipid Res. 32:1991;1325-1332.
47. Jialal I., Grundy S.M. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoproteins. J. Lipid Res. 33:1992;899-906.
48. Calzada C., Bizzotto M., Paganga G., Miller N.J., Bruckdorfer K.J., Diplock A.T., Rice-Evans C.A. Levels of antioxidant nutrients in plasma and low density lipoproteins: a human volunteer supplementation study. Free Rad. Res. 23:1995;489-503.
49. Stibert P.L., Leong L.L., Sturm M.J., Stropham J., Taylor R.R. Short term vitamin E supplementation has no effect on platelet function, plasma phospholipase A2 and lyso-PAF in male volunteers. Clin. Exp. Pharmacol. Physiol. 17:1990;645-651.
50. Abbey M., Nestel P.J., Baghurst P.A. Antioxidant vitamins and low-density lipoprotein oxidation. Am. J. Clin. Nutr. 58:1993;525-532.
51. Vatassery G.T., Krezowski A.M., Eckfeld J.H. Vitamin E concentration in human blood plasma and platelets. Am. J. Clin. Nutr. 37:1983;1020-1024.
52. Lehmann J., Rao D.D., Canary J.J., Judd J.T. Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes and red blood cells. Am. J. Clin. Nutr. 47:1988;470.
53. Weiss S.J., Turk J., Needleman P.A. Mechanism for the hydroperoxide-mediated inactivation of prostacyclin synthetase. Blood. 53(11):1979;916.
54. Freedman J.E., Farhat J.H., Loscalzo J., Keaney J.F. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase c-dependent mechanism. Circulation. 94:1996;2434-2440.
55. Sevitt S. Platelets and foam cells in the evolution of atherosclerosis. Histological and immunological studies of human lesions. Atherosclerosis. 61:1986;107-110.
56. Aviram M. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation. Thromb. Haemostas. 74:1995;560-564.
57. Ardlie N.G., Selley M.L., Simons L.A. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis. 76:1989;117-124.
58. Rijike Y.B., Vogelgzang C.J.M., Van Berkel T.J.C., Princen H.M.G., Verwey H.F., Van der Laarse A., Bruschke A.V.G. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients. Lancet. 340:1992;858-859.
59. Cominacini L., Garbini U., Pastorino A.M. et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 99:1993;63-70.
60. van de Vijver L.P., Kardinaal A.F., van Duyvenvoorde W., Kruijssen D.A., Grobbee D.E., van Poppel G., Princen H.M. LDL oxidation and extent of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18:1998;193-199.
61. Rapola J.M., Virtamo J., Ripatti S., Huttunen J.K., Albanes D., Taylor P.R., Heinonen O.P. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720.
62. Virtamo J., Rapola J.M., Ripatti S., Heinonen O.P., Taylor P.R., Albanes D., Huttunen J.K. Effect of vitamin E and beta-carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch. Int. Med. 158:1998;668-675.